WBA logo

Walgreens Boots Alliance (WBA) Cash and cash equivalents

annual cash & cash equivalents:

$1.32B+$591.00M(+81.18%)
August 31, 2024

Summary

  • As of today (May 29, 2025), WBA annual cash & cash equivalents is $1.32 billion, with the most recent change of +$591.00 million (+81.18%) on August 31, 2024.
  • During the last 3 years, WBA annual cash & cash equivalents has risen by +$760.00 million (+135.96%).
  • WBA annual cash & cash equivalents is now -86.55% below its all-time high of $9.81 billion, reached on August 31, 2016.

Performance

1-year change

+81.18%

3-year change

+135.96%

5-year change

+28.93%

15-year change

-60.04%

WBA Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.39%
WBA annual cash & cash equivalents is higher than 95.39% of companies in Healthcare sector

Range

All-time high

$9.81B
WBA annual cash & cash equivalents is currently -86.55% below its historical high of $9.81 billion

3-year low

$559.00M
WBA annual cash & cash equivalents is currently +135.96% above its 3-year low

Earnings dates

Last annual earnings report date

Aug 31, 2024
WBA previous annual earnings announcement was published on Aug 31, 2024

Next annual earnings report date

N/A
WBA next annual earnings announcement has not yet been scheduled

OtherWBAbalance sheet metrics

quarterly total assets

$70.22B
WBA quarterly total assets is $70.22 billion

quarterly current assets

$16.24B
WBA quarterly total current assets is $16.24 billion

quarterly total liabilities

$62.96B
WBA quarterly total liabilities is $62.96 billion

quarterly current liabilities

$26.59B
WBA quarterly total current liabilities is $26.59 billion

quarterly cash & cash equivalents:

$702.00M-$157.00M(-18.28%)
February 28, 2025

Summary

  • As of today (May 29, 2025), WBA quarterly cash & cash equivalents is $702.00 million, with the most recent change of -$157.00 million (-18.28%) on February 28, 2025.
  • Over the past year, WBA quarterly cash & cash equivalents has increased by +$34.00 million (+5.09%).
  • WBA quarterly cash & cash equivalents is now -94.54% below its all-time high of $12.86 billion, reached on November 30, 2014.

Performance

3-month change

-18.28%

1-year change

+5.09%

3-year change

-62.8%

5-year change

-11.36%

WBA quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

93.16%
WBA quarterly cash & cash equivalents is higher than 93.16% of companies in Healthcare sector

Range

All-time high

$12.86B
WBA quarterly cash & cash equivalents is currently -94.54% below its historical high of $12.86 billion

3-year low

$668.00M
WBA quarterly cash & cash equivalents is currently +5.09% above its 3-year low

Earnings dates

Last quarterly earnings report date

Feb 28, 2025
WBA previous earnings announcement was published on Feb 28, 2025

Next quarterly earnings report date

Jun 27, 2025
WBA next earnings announcement is scheduled for Jun 27, 2025

OtherWBAbalance sheet metrics

quarterly total assets

$70.22B
WBA quarterly total assets is $70.22 billion

quarterly current assets

$16.24B
WBA quarterly total current assets is $16.24 billion

quarterly total liabilities

$62.96B
WBA quarterly total liabilities is $62.96 billion

quarterly current liabilities

$26.59B
WBA quarterly total current liabilities is $26.59 billion

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

WBA Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+81.2%+5.1%
3 y3 years+136.0%-62.8%
5 y5 years+28.9%-11.4%

WBA Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.9%+136.0%-70.1%+5.1%
5 y5-year-2.9%+181.2%-83.0%+49.7%
alltimeall time-86.5%>+9999.0%-94.5%+9136.8%

WBA Cash and cash equivalents History

DateAnnualQuarterly
Feb 2025
-
$702.00M(-18.3%)
Nov 2024
-
$859.00M(-34.9%)
Aug 2024
$1.32B(+81.2%)
$1.32B(+87.6%)
May 2024
-
$703.00M(+5.2%)
Feb 2024
-
$668.00M(-14.8%)
Nov 2023
-
$784.00M(+7.7%)
Aug 2023
$728.00M(-46.4%)
$728.00M(-16.4%)
May 2023
-
$871.00M(-19.9%)
Feb 2023
-
$1.09B(-53.7%)
Nov 2022
-
$2.35B(+73.0%)
Aug 2022
$1.36B(+142.9%)
$1.36B(-40.6%)
May 2022
-
$2.29B(+21.1%)
Feb 2022
-
$1.89B(-54.4%)
Nov 2021
-
$4.13B(+639.7%)
Aug 2021
$559.00M(+19.2%)
$559.00M(-58.4%)
May 2021
-
$1.34B(+30.6%)
Feb 2021
-
$1.03B(-7.3%)
Nov 2020
-
$1.11B(+136.9%)
Aug 2020
$469.00M(-54.2%)
$469.00M(-38.9%)
May 2020
-
$768.00M(-3.0%)
Feb 2020
-
$792.00M(-2.3%)
Nov 2019
-
$811.00M(-20.7%)
Aug 2019
$1.02B(+30.3%)
$1.02B(+21.9%)
May 2019
-
$839.00M(+2.6%)
Feb 2019
-
$818.00M(-16.5%)
Nov 2018
-
$980.00M(+24.8%)
Aug 2018
$785.00M(-76.2%)
$785.00M(-56.8%)
May 2018
-
$1.82B(+3.9%)
Feb 2018
-
$1.75B(-4.4%)
Nov 2017
-
$1.83B(-44.6%)
Aug 2017
$3.30B(-66.3%)
$3.30B(-73.1%)
May 2017
-
$12.25B(+3.6%)
Feb 2017
-
$11.82B(+23.2%)
Nov 2016
-
$9.60B(-2.1%)
Aug 2016
$9.81B(+226.9%)
$9.81B(+198.0%)
May 2016
-
$3.29B(-8.2%)
Feb 2016
-
$3.59B(+39.5%)
Nov 2015
-
$2.57B(-14.3%)
Aug 2015
$3.00B(+13.4%)
$3.00B(-32.6%)
May 2015
-
$4.45B(+48.1%)
Feb 2015
-
$3.00B(-76.6%)
Nov 2014
-
$12.86B(+386.1%)
Aug 2014
$2.65B(+25.6%)
$2.65B(+24.5%)
May 2014
-
$2.13B(+19.6%)
Feb 2014
-
$1.78B(+83.4%)
Nov 2013
-
$969.00M(-54.0%)
Aug 2013
$2.11B(+62.4%)
$2.11B(-29.7%)
May 2013
-
$2.99B(+23.2%)
Feb 2013
-
$2.43B(+32.9%)
Nov 2012
-
$1.83B(+41.0%)
Aug 2012
$1.30B(-16.6%)
$1.30B(-35.0%)
May 2012
-
$2.00B(+84.0%)
Feb 2012
-
$1.08B(-0.9%)
Nov 2011
-
$1.09B(-29.7%)
Aug 2011
$1.56B(-17.2%)
$1.56B(-41.3%)
May 2011
-
$2.65B(+18.2%)
Feb 2011
-
$2.24B(+8.8%)
Nov 2010
-
$2.06B(+9.7%)
Aug 2010
$1.88B(-9.9%)
$1.88B(+9.8%)
May 2010
-
$1.71B(-31.5%)
Feb 2010
-
$2.50B(-2.0%)
Nov 2009
-
$2.55B(+22.3%)
Aug 2009
$2.09B(+371.1%)
$2.09B(-9.3%)
May 2009
-
$2.30B(+153.0%)
Feb 2009
-
$909.00M(+2.6%)
Nov 2008
-
$886.00M(+100.0%)
Aug 2008
$443.00M(+73.9%)
$443.00M(-6.1%)
May 2008
-
$471.80M(+84.8%)
Feb 2008
-
$255.30M(-13.5%)
Nov 2007
-
$295.10M(+15.8%)
Aug 2007
$254.80M(-72.3%)
$254.80M(-55.1%)
May 2007
-
$567.40M(-18.3%)
Feb 2007
-
$694.20M(+3.7%)
Nov 2006
-
$669.70M(-27.2%)
DateAnnualQuarterly
Aug 2006
$919.90M(+59.5%)
$919.90M(+14.6%)
May 2006
-
$802.40M(+38.6%)
Feb 2006
-
$578.80M(-0.9%)
Nov 2005
-
$584.10M(+1.3%)
Aug 2005
$576.80M(+29.9%)
$576.80M(+6.6%)
May 2005
-
$541.20M(+19.4%)
Feb 2005
-
$453.10M(-65.5%)
Nov 2004
-
$1.31B(+195.8%)
Aug 2004
$444.00M(-65.0%)
$444.00M(-71.8%)
May 2004
-
$1.58B(+42.4%)
Feb 2004
-
$1.11B(+27.5%)
Nov 2003
-
$868.10M(-31.5%)
Aug 2003
$1.27B(+181.8%)
$1.27B(+48.4%)
May 2003
-
$854.40M(+25.1%)
Feb 2003
-
$683.20M(+132.1%)
Nov 2002
-
$294.30M(-34.6%)
Aug 2002
$449.90M(+2562.1%)
$449.90M(+57.2%)
May 2002
-
$286.20M(+1677.6%)
Feb 2002
-
$16.10M(-53.1%)
Nov 2001
-
$34.30M(+103.0%)
Aug 2001
$16.90M(+32.0%)
$16.90M(-82.9%)
May 2001
-
$98.70M(+32.3%)
Feb 2001
-
$74.60M(+425.4%)
Nov 2000
-
$14.20M(+10.9%)
Aug 2000
$12.80M(-91.0%)
$12.80M(-72.8%)
May 2000
-
$47.00M(+298.3%)
Feb 2000
-
$11.80M(-1.7%)
Nov 1999
-
$12.00M(-91.5%)
Aug 1999
$141.80M(-1.8%)
$141.80M(-44.5%)
May 1999
-
$255.30M(-3.1%)
Feb 1999
-
$263.60M(+133.3%)
Nov 1998
-
$113.00M(-21.7%)
Aug 1998
$144.40M(+97.8%)
$144.40M(+30.1%)
May 1998
-
$111.00M(+217.1%)
Feb 1998
-
$35.00M(+150.0%)
Nov 1997
-
$14.00M(-80.8%)
Aug 1997
$73.00M(+729.5%)
$73.00M(-47.0%)
May 1997
-
$137.70M(+558.9%)
Feb 1997
-
$20.90M(-30.6%)
Nov 1996
-
$30.10M(+242.0%)
Aug 1996
$8.80M(-60.4%)
$8.80M(-81.7%)
May 1996
-
$48.10M(+516.7%)
Feb 1996
-
$7.80M(+2.6%)
Nov 1995
-
$7.60M(-65.8%)
Aug 1995
$22.20M(-71.5%)
$22.20M(-80.9%)
May 1995
-
$116.00M(+117.2%)
Feb 1995
-
$53.40M(+229.6%)
Nov 1994
-
$16.20M(-79.2%)
Aug 1994
$77.90M(-15.0%)
$77.90M(-56.7%)
May 1994
-
$179.90M(+270.9%)
Feb 1994
-
$48.50M(+119.5%)
Nov 1993
-
$22.10M(-75.9%)
Aug 1993
$91.60M(-36.6%)
$91.60M(-49.0%)
May 1993
-
$179.60M(+257.8%)
Feb 1993
-
$50.20M(-47.3%)
Nov 1992
-
$95.20M(-34.1%)
Aug 1992
$144.50M(+100.7%)
$144.50M(-15.3%)
May 1992
-
$170.70M(+8.7%)
Feb 1992
-
$157.00M(+167.5%)
Nov 1991
-
$58.70M(-18.5%)
Aug 1991
$72.00M(-66.3%)
$72.00M(-64.1%)
May 1991
-
$200.40M(-5.6%)
Feb 1991
-
$212.30M(+34.7%)
Nov 1990
-
$157.60M(-26.3%)
Aug 1990
$213.90M(-5.1%)
$213.90M(-12.0%)
May 1990
-
$243.10M(+2.1%)
Feb 1990
-
$238.20M(+32.2%)
Nov 1989
-
$180.20M(-20.1%)
Aug 1989
$225.50M(+7.5%)
$225.50M(+7.5%)
Aug 1988
$209.70M(+409.0%)
$209.70M(+409.0%)
Aug 1987
$41.20M(-58.0%)
$41.20M(-58.0%)
Aug 1986
$98.10M(+19.1%)
$98.10M(+19.1%)
Aug 1985
$82.40M(+45.6%)
$82.40M(+45.6%)
Aug 1984
$56.60M
$56.60M

FAQ

  • What is Walgreens Boots Alliance annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Walgreens Boots Alliance?
  • What is Walgreens Boots Alliance annual cash & cash equivalents year-on-year change?
  • What is Walgreens Boots Alliance quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Walgreens Boots Alliance?
  • What is Walgreens Boots Alliance quarterly cash & cash equivalents year-on-year change?

What is Walgreens Boots Alliance annual cash & cash equivalents?

The current annual cash & cash equivalents of WBA is $1.32B

What is the all time high annual cash & cash equivalents for Walgreens Boots Alliance?

Walgreens Boots Alliance all-time high annual cash & cash equivalents is $9.81B

What is Walgreens Boots Alliance annual cash & cash equivalents year-on-year change?

Over the past year, WBA annual cash & cash equivalents has changed by +$591.00M (+81.18%)

What is Walgreens Boots Alliance quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of WBA is $702.00M

What is the all time high quarterly cash & cash equivalents for Walgreens Boots Alliance?

Walgreens Boots Alliance all-time high quarterly cash & cash equivalents is $12.86B

What is Walgreens Boots Alliance quarterly cash & cash equivalents year-on-year change?

Over the past year, WBA quarterly cash & cash equivalents has changed by +$34.00M (+5.09%)
On this page